Related by context. Frequent words. (Click for all words.) 76 liposomal formulation 73 SCH # 72 Initiate Phase 72 elotuzumab 72 phase IIb clinical 72 Panzem R 72 metastatic castration resistant 72 HCV protease inhibitor 71 multi kinase inhibitor 71 proteasome inhibitor 71 forodesine 71 Pegasys R 70 Pivotal Phase 70 Cetrorelix 70 phase IIa clinical 70 relapsed refractory multiple myeloma 70 anticancer compound 70 Pivotal Phase III 70 Pegasys ® 69 nitazoxanide 69 PEG SN# 69 R sorafenib tablets 69 Nexavar ® 69 orally bioavailable 69 metastatic hormone refractory 69 Phase 1b trial 69 Initiates Phase 69 Presents Positive 69 MEK inhibitor 69 HGS ETR1 69 INCB# [001] 69 Carfilzomib 69 Chronic Hepatitis C 69 pertuzumab 69 Epratuzumab 69 FDA Accepts 69 ocrelizumab 69 MKC# 68 mTOR inhibitor 68 BAY #-# 68 KNS # 68 Advancing Drugs 68 Rebif ® 68 AVE# 68 Phase IIb trials 68 Dasatinib 68 Amrubicin 68 relapsed multiple myeloma 68 Boceprevir 68 diabetic neuropathic pain 68 Vytorin combines 68 Ixempra 68 Completes Enrollment 68 rNAPc2 68 HCV protease 68 Entereg R 68 sodium Injection 68 interferon alfa 68 KRN# 68 Phase 2a trial 68 Drug Candidate 68 Irinotecan 68 Voreloxin 68 CORT # 68 Phase Ib clinical 68 Traficet EN 68 active comparator 68 Pirfenidone 67 Phase III Clinical Trial 67 ALN TTR# 67 Aliskiren 67 subcutaneous formulation 67 ganetespib 67 luteinizing hormone releasing 67 refractory multiple myeloma 67 Recombinant Human 67 DAVANAT 67 Inc. Nasdaq IMGN 67 TLR9 agonist 67 Laquinimod 67 peginterferon alfa 2b 67 investigational oral 67 plus prednisone 67 CYC# 67 PS# [001] 67 humanized anti 67 tanespimycin 67 dipropionate 67 SAR# [004] 67 thymalfasin 67 deforolimus 67 mRCC 67 transcriptase inhibitor NNRTI 67 Sym# 67 Application BLA 67 Pegintron 67 COPEGUS 67 administered subcutaneously 67 NVA# 67 Guanilib 67 Metastatic Melanoma